Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2017 | 03-2017 | 12-2016 | |
| Operating Expenses | 6,218 | 5,208 | 0 |
| Operating Income | -6,218 | -5,208 | N/A |
| Interest Expense | 75 | 72 | 0 |
| Other Income | -68 | -90 | 0 |
| Pre-tax Income | -6,361 | -5,370 | 0 |
| Net Income Continuous | -6,361 | -5,370 | N/A |
| Net Income | $-6,361 | $-5,370 | $N/A |
| EPS Basic Total Ops | -41.80 | -36.20 | N/A |
| EPS Basic Continuous Ops | -34.10 | -29.41 | N/A |
| EPS Diluted Total Ops | -41.80 | -36.20 | N/A |
| EPS Diluted Continuous Ops | -34.10 | -29.41 | N/A |
| EBITDA(a) | $-6,031 | $-5,045 | $N/A |